V. Vila

895 total citations
34 papers, 559 citations indexed

About

V. Vila is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Hematology. According to data from OpenAlex, V. Vila has authored 34 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in V. Vila's work include Blood properties and coagulation (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). V. Vila is often cited by papers focused on Blood properties and coagulation (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). V. Vila collaborates with scholars based in Spain, United States and Mexico. V. Vila's co-authors include E. Regañón, José A. Aznar, Francisco España, A. Estellés, J Aznar, Luis Ramón, M. Chirivella, Remedios Castelló, Juan Gilabert–Estellés and Vicenta Martı́nez-Sales and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Human Reproduction.

In The Last Decade

V. Vila

31 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Vila Spain 14 141 112 109 96 77 34 559
France Ziereisen Belgium 12 41 0.3× 75 0.7× 51 0.5× 26 0.3× 138 1.8× 29 693
Isa Abdi Rad Iran 12 44 0.3× 61 0.5× 52 0.5× 24 0.3× 71 0.9× 59 448
İbrahim Serdar Serin Türkiye 14 24 0.2× 28 0.3× 185 1.7× 235 2.4× 73 0.9× 30 571
Andrew Loughney United Kingdom 13 57 0.4× 33 0.3× 44 0.4× 104 1.1× 73 0.9× 24 513
Giuseppe Noia Italy 14 57 0.4× 79 0.7× 31 0.3× 55 0.6× 172 2.2× 56 512
Shannon S. Wu United States 14 22 0.2× 84 0.8× 22 0.2× 153 1.6× 173 2.2× 51 662
Menachem Granat Israel 10 14 0.1× 42 0.4× 262 2.4× 108 1.1× 168 2.2× 24 699
R. Nuran Turksoy United States 11 29 0.2× 16 0.1× 281 2.6× 108 1.1× 43 0.6× 26 660
M Gojnić Serbia 11 23 0.2× 49 0.4× 37 0.3× 173 1.8× 83 1.1× 55 461
Dag Wide‐Swensson Sweden 17 22 0.2× 140 1.3× 35 0.3× 547 5.7× 78 1.0× 33 886

Countries citing papers authored by V. Vila

Since Specialization
Citations

This map shows the geographic impact of V. Vila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vila more than expected).

Fields of papers citing papers by V. Vila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Vila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vila. The network helps show where V. Vila may publish in the future.

Co-authorship network of co-authors of V. Vila

This figure shows the co-authorship network connecting the top 25 collaborators of V. Vila. A scholar is included among the top collaborators of V. Vila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Vila. V. Vila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fleitas, Tania, Vicenta Martı́nez-Sales, V. Vila, et al.. (2013). VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer. Clinical & Translational Oncology. 15(11). 897–902. 28 indexed citations
3.
4.
Martínez‐Dolz, Luis, Luís Almenar, E. Regañón, et al.. (2009). What is the best biomarker for diagnosis of rejection in heart transplantation?. Clinical Transplantation. 23(5). 672–680. 23 indexed citations
5.
Pons, S., Vicente Zanón‐Moreno, Pedro Lopes de Melo, et al.. (2007). Neuropatía óptica inducida por exposición prenatal a drogas o alcohol. Archivos de la Sociedad Española de Oftalmología. 82(1). 21–6. 8 indexed citations
6.
Gilabert–Estellés, Juan, Luis Ramón, Francisco España, et al.. (2007). Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Human Reproduction. 22(8). 2120–2127. 112 indexed citations
7.
Almenar, Luís, Luis Martínez‐Dolz, E. Regañón, et al.. (2006). Diagnostic Usefulness of Inflammatory Markers in Acute Cellular Rejection After Heart Transplantation. Transplantation Proceedings. 38(8). 2569–2571. 7 indexed citations
8.
9.
Martı́nez-Sales, Vicenta, et al.. (1998). Elevated Thrombotic Activity after Myocardial Infarction: A 2-Year Follow-Up Study. Pathophysiology of Haemostasis and Thrombosis. 28(6). 301–306. 24 indexed citations
10.
Regañón, E., Fernando Ferrando, V. Vila, et al.. (1998). Increase in Thrombin Generation after Coronary Thrombolysis with rt-PA or Streptokinase with Simultaneous Heparin versus Heparin Alone. Pathophysiology of Haemostasis and Thrombosis. 28(2). 99–105. 5 indexed citations
11.
Gómez-Beneyto, Manuel, et al.. (1994). Prevalence of mental disorders among children in Valencia, Spain. Acta Psychiatrica Scandinavica. 89(5). 352–357. 52 indexed citations
12.
Regañón, E., V. Vila, Begoña Laíz, J. Gilabert, & J Aznar. (1993). Decreased High-Molecular Weight Fibrinogen and Impaired Alpha-Chain Polymerization in Full-Term Newborns. Pathophysiology of Haemostasis and Thrombosis. 23(3). 149–158. 7 indexed citations
13.
Gjerset, Ruth A., J Yeargin, Sarah K. Volkman, et al.. (1990). Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype.. The Journal of Immunology. 145(10). 3497–3501. 45 indexed citations
14.
Gilabert, J., et al.. (1987). Congenital Hypofibrinogenemia and Pregnancy, Obstetric and Hematological Management. Gynecologic and Obstetric Investigation. 24(4). 271–276. 9 indexed citations
15.
Vila, V., E. Regañón, José A. Aznar, Gemma Navarro, & M. Salas. (1986). Characterization of fibrinogen Barcelona 1 (FB): Congenital dysfibrinogenemia with defective release of fibrinopeptide A and abnormal plasmic degradation. Thrombosis Research. 41. 31–31. 1 indexed citations
16.
Regañón, E., V. Vila, & José A. Aznar. (1984). Gelation of Fibrinogen in Plasma. Pathophysiology of Haemostasis and Thrombosis. 14(2). 170–178. 14 indexed citations
17.
Regañón, E., V. Vila, & José A. Aznar. (1984). Effect of calcium ions on fibrin gel formation in normal plasma. Thrombosis Research. 35(3). 365–369. 6 indexed citations
18.
Aznar, J, A. Estellés, V. Vila, et al.. (1984). Inherited Fibrinolytic Disorder Due to an Enhanced Plasminogen Activator Level. Thrombosis and Haemostasis. 52(2). 196–200. 29 indexed citations
19.
Vila, V., E. Regañón, & José A. Aznar. (1978). Isolation of fibrin(OGEN) degradation products from normal plasma by affinity chromatographic study. Clinica Chimica Acta. 87(2). 245–252. 6 indexed citations
20.
Regañón, E., José A. Aznar, & V. Vila. (1977). Degradation of human fibrinogen by plasmin: A kinetic study. Thrombosis Research. 10(3). 411–419. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by France Ziereisen Breakdown of academic impact, for papers by Isa Abdi Rad Breakdown of academic impact, for papers by İbrahim Serdar Serin Breakdown of academic impact, for papers by Andrew Loughney Breakdown of academic impact, for papers by Giuseppe Noia Breakdown of academic impact, for papers by Shannon S. Wu Breakdown of academic impact, for papers by Menachem Granat Breakdown of academic impact, for papers by R. Nuran Turksoy Breakdown of academic impact, for papers by M Gojnić Breakdown of academic impact, for papers by Dag Wide‐Swensson
Rankless by CCL
2026